Clinical Study
Correlation of High-Risk Soft Tissue Sarcoma Biomarker Expression Patterns with Outcome following Neoadjuvant Chemoradiation
Table 1
Changes in tumor biomarker expression following neoadjuvant chemoradiation in 12 “matched pair” large, deep, high-risk soft tissue sarcoma patients.
| Marker | Pretreatment value | Posttreatment value | value | Mean | SD | Mean | SD |
| ACIS Ki67 | | | | | | Percentage | 15.91 | 19.78 | 7.65 | 7.30 | 0.0674 | p53 | | | | | | Nuclear/cytoplasmic ratio | 1.44 | 0.22 | 1.90 | 0.74 | 0.0469 | ATM | | | | | | Nuclear | 8349.36 | 1920.35 | 7870.75 | 2114.36 | 0.4961 | Cytoplasm | 3811.69 | 2121.29 | 3116.21 | 1035.73 | 0.4258 | Tumor mask | 5289.39 | 2400.71 | 4412.80 | 1205.37 | 0.3594 | PARP1 | | | | | | Nuclear | 7042.80 | 1361.76 | 5533.59 | 1198.18 | 0.0313 | Cytoplasm | 3281.97 | 798.55 | 2293.63 | 471.64 | 0.0938 | Tumor mask | 4354.82 | 1092.11 | 3263.65 | 674.80 | 0.0625 | ERCC1 | | | | | | Nuclear | 9433.46 | 2247.20 | 8586.98 | 1658.74 | 0.3594 | Cytoplasm | 3046.29 | 1563.80 | 2197.19 | 917.54 | 0.0977 | Tumor mask | 5150.35 | 1600.28 | 4206.67 | 1335.08 | 0.0977 | XPF | | | | | | Nuclear | 8772.27 | 1076.08 | 8880.11 | 2407.45 | 0.8457 | Cytoplasm | 4694.75 | 1556.58 | 4240.83 | 1254.75 | 0.3750 | Tumor mask | 6004.00 | 1598.71 | 5511.37 | 1619.80 | 0.4316 | CAIX | | | | | | Nuclear | 3939.81 | 1273.12 | 2406.95 | 977.10 | 0.0234 | Cytoplasm | 3931.01 | 1699.38 | 2037.18 | 944.15 | 0.0391 | Tumor mask | 3972.93 | 1569.58 | 2124.05 | 926.91 | 0.0156 | GLUT1 | | | | | | Nuclear | 5389.90 | 2886.98 | 2937.34 | 1198.24 | 0.0781 | Cytoplasm | 4932.26 | 3106.79 | 2496.81 | 1116.73 | 0.1094 | Tumor mask | 5054.19 | 2998.35 | 2658.88 | 1128.22 | 0.0469 | HIF-1α | | | | | | Nuclear | 6267.08 | 1603.95 | 5787.91 | 2241.58 | 0.4609 | Cytoplasm | 3857.75 | 1221.78 | 2978.52 | 1433.30 | 0.1484 | Tumor mask | 4582.47 | 1435.49 | 4009.57 | 2108.14 | 0.3828 |
|
|
SD: standard deviation; values are from the Wilcoxon signed-rank test on log-transformed values. |